Newsstand
Featured
Magazines
Catalogues
eBooks
Others
Log In
Sign up
Click to read
Comments
Tweet
Pharmaceuticals and Healthcare Reports
Japan Dyslipidemia Market
Published on
26 April 2017
in “
Health & Fitness
,
Health & Fitness
”, language —
English
. 3 pages.
Publication description:
The launch of the proprotein convertase subtilisin/kexin type 9 (PCSK9) biologics and the cholesteryl ester transfer protein (CETP) inhibitors will reshape the sales landscape of the dyslipidemia market moving forward.
More
Show Tags
Tags:
japan dyslipidemia market analysis
Read
Download
Subscribe for FREE
Subscribe
You are subscribed!
Other publications of “Pharmaceuticals and Healthcare Reports”
View all publications
Related Magazines
